AAAAI logo
Live sample coverage from TikTok · July 26, 2026

AAAAI. Watched in real time.

dig delivers a live read on the forces shaping brands across social, from creator sparks and product launches to cultural shifts and emerging narratives.

Trending narrative
The allergy, asthma and immunology conversation AAAAI represents is loud and personal on TikTok: needle-free epinephrine is the breakout story, patients share safe-food life and oral-immunotherapy wins, EpiPen confidence is its own genre, and the sharpest notes are the eczema steroid-withdrawal debate and being dismissed when an allergy is real.
Trending now · pulled from dig
Narrative intelligence

The stories driving the AAAAI conversation.

Narratives, not hashtags. dig surfaces the meaning behind each clip, ranking the stories by momentum and breaking them down by generation.

Trending now · last 7 days

What people really think about AAAAI right now.

Pre-crisis radar · for comms

The narratives that haven't hit yet.

Early negative signals that give comms a head start before the story spreads.

Emerging signals · last 14 days
See the signals before they break.
The accelerating narratives, who's driving them, and why they matter. Visible only to dig customers.
Book a demo to unlock
Owned content vs. UGC

Who's actually calling the AAAAI conversation.

A category view of the allergy, asthma and immunology conversation on public social, carried by patients, allergy parents and allergists rather than the professional societies.

Owned vs. UGC reach · last 30 days
~10%vs~90%
Owned share · UGC share of AAAAI TikTok reach (30d)
This is a category read, not a society feed: AAAAI itself is barely present on TikTok, so the conversation is carried by patients, allergy parents, and allergists, plus the occasional pharma launch. Reach sits with voices like @rubin_allergy and @jennaxhealth, not the professional bodies.
Top 6 creators · last 7 days
See the creators moving AAAAI's allergy and immunology conversation.
Creator type, narratives, follower counts, and recommended actions.
Book a demo to unlock
The house codes

The needle-free epinephrine moment, the safe-food community, oral-immunotherapy wins, EpiPen confidence, the eczema steroid-withdrawal debate, and being dismissed. Tracked.

Each storyline shaping how allergy, asthma and immunology show up on social, including the safety and credibility debates the specialty has to watch.

Portfolio signal · last 30 days
See every franchise in the house.
Each product line's top narrative and the surprise signal comms may not see coming yet. Visible only to dig customers.
Book a demo to unlock
From signal to next move

The actions your team can take this week.

The creator to engage, the narrative to get ahead of, and the talking point that needs to be ready before the story moves.

Your next moves.
The creator to seed, the narrative to boost, and the talking point to sharpen this week.
Book a demo to unlock